Memoril Mite (Piracetam)

Piracetam is thought to improve neuronal membrane fluidity and modulate ion channels, which enhances neurotransmitter release and cerebral blood flow, thereby supporting synaptic transmission and cognitive function.

The appropriate dose of piracetam is determined by the prescribing clinician based on the patient’s condition, age, renal function, and treatment goals. Dosage regimens may vary and should follow the prescriber’s instructions.

Safety data for piracetam in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Memoril Mite, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Piracetam belongs to the racetam class, which differs from other cognitive enhancers such as cholinesterase inhibitors or nootropics like modafinil. While piracetam primarily modulates membrane fluidity and neurotransmission, other agents may target different pathways, resulting in varied efficacy and safety profiles.

Memoril Mite should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain its stability and potency.

Memoril Mite is intended for oral administration. The tablet or capsule should be taken with water, and the exact dosing schedule should follow the prescriber’s directions.

Serious risks, though rare, include severe skin reactions, thrombocytopenia, depression, seizures, and anaphylactic responses. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with known hypersensitivity to piracetam or any of its excipients, those with severe renal impairment without dose adjustment, and patients who have experienced serious adverse reactions to the drug should avoid its use.